mTOR Signaling and Cancer Progression
Cancer-Critical Genes I: Proto-oncogenes
Tumor Immunotherapy
Targeted Cancer Therapies
Inflammatory Bowel Disease V: Surgical Management
Cancer Survival Analysis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
1Klinik für Ohren-, Nasen-, Hals- und Gesichtschirurgie, Universitätsspital Zürich. gerry.huber@usz.ch
Identifying molecular markers could improve head and neck cancer prognostication. This helps detect occult metastases in early tumors, guiding surgical treatment decisions for better patient outcomes.
Area of Science:
Context:
Purpose:
Summary:
Impact: